SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-20-000116
Filing Date
2020-12-10
Accepted
2020-12-10 16:09:28
Documents
4
Period of Report
2020-12-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kpontifaxagreement.htm 8-K 33862
2 EX-99.1 debtagreement1210final.htm EX-99.1 9665
3 EX-10.1 pontifaxopiant-notepur.htm EX-10.1 330968
4 EX-4.1 pontifaxopiantregistra.htm EX-4.1 117082
  Complete submission text file 0001385508-20-000116.txt   493124
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 201380642
SIC: 2834 Pharmaceutical Preparations